MAOB and early-onset autosomal dominant Alzheimer disease: The neuroprotective effects of MAO B inhibitors also provide the rationale for their potential in Alzheimer’s disease (AD), particularly for the efficacy of MAO B inhibition in reducing ROS toxicity and oxidative stress (OS) [16].